All topical ophthalmic fluoroquinolones are approved for patients 1 year of age and older EXCEPT which drug?

Prepare for the KMK Live Session General Pharmacy Test. Use flashcards and multiple-choice questions with hints and explanations for each question. Get ready for your exam with confidence!

Multiple Choice

All topical ophthalmic fluoroquinolones are approved for patients 1 year of age and older EXCEPT which drug?

Explanation:
Understanding age approvals for eye antibiotics is key. Most topical fluoroquinolones have FDA labeling that allows use in children 1 year of age and older, meaning they’ve been studied and deemed safe and effective enough for pediatric patients. Moxifloxacin, ciprofloxacin, and gatifloxacin all have such pediatric approvals and are commonly used in kids for conjunctivitis and other ocular infections. Levofloxacin ophthalmic solution, however, does not have approved pediatric labeling; its use is restricted to adults. This difference in approved age groups makes it the exception. In other words, the other three drugs can be used in children 1 year and older, while levofloxacin is not approved for that age group based on current labeling.

Understanding age approvals for eye antibiotics is key. Most topical fluoroquinolones have FDA labeling that allows use in children 1 year of age and older, meaning they’ve been studied and deemed safe and effective enough for pediatric patients. Moxifloxacin, ciprofloxacin, and gatifloxacin all have such pediatric approvals and are commonly used in kids for conjunctivitis and other ocular infections.

Levofloxacin ophthalmic solution, however, does not have approved pediatric labeling; its use is restricted to adults. This difference in approved age groups makes it the exception. In other words, the other three drugs can be used in children 1 year and older, while levofloxacin is not approved for that age group based on current labeling.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy